Elevated Expression of CHAF1A in Hepatocellular Carcinoma Progression and Immune Modulation

Clinical and Experimental Gastroenterology · Published 2025-04-01 · DOI 10.2147/ceg.s500029

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/ceg.s500029

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• CHAF1A identified as a candidate biomarker and potential therapeutic target in Burkitt lymphoma through integrated bioinformatics and histopathological analysis · Hematology · 2026 · Cites or is cited by this article
• Expert Opinion on the Management, Challenges, and Knowledge Gaps Pertaining to Eosinophilic Esophagitis Among Adults in the Greater Gulf Region · Clinical and Experimental Gastroenterology · 2025 · Same journal
• Serological Markers of Intestinal Barrier Function and Inflammation as Potential Predictors of Recurrent Primary Sclerosing Cholangitis · Clinical and Experimental Gastroenterology · 2025 · Same journal
• Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications · Clinical and Experimental Gastroenterology · 2026 · Same journal
• Characterization of Bacterial Biofilm Composition in Occluded Plastic Biliary Stents · Clinical and Experimental Gastroenterology · 2025 · Same journal
• Helicobacter pylori and Cancer: What’s the Link? · Clinical and Experimental Gastroenterology · 2026 · Same journal
• Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date · Clinical and Experimental Gastroenterology · 2024 · Same journal
• Management and Treatment of Perianal Fistulizing Crohn’s Disease · Clinical and Experimental Gastroenterology · 2025 · Same journal
• Patient-Generated Images in Perianal Disease: An Evolving Tool in Proctology · Clinical and Experimental Gastroenterology · 2024 · Same journal
• Tumor-Stroma Ratio is a Critical Indicator of Peritoneal Metastasis in Gastric Cancer · Clinical and Experimental Gastroenterology · 2025 · Same journal